← Leaderboards
Amy Caroline Justice
Philadelphia Va Medical Center
$51,314,210
Attributed
$56,891,925
Total exposure
21
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$64,708,605 · 21
VA$0 · 2
By mechanism
U01$20,738,183 · 3
U10$12,669,210 · 1
R01$10,919,422 · 4
P01$9,288,057 · 4
U24$7,278,862 · 2
P60$1,954,943 · 2
Top collaborators
- Matthew S Freiberg13 shared
- Henry Richard Kranzler7 shared
- Vincent Lo Re6 shared
- David Fiellin3 shared
- Chung-Chou Ho Chang1 shared
- Daniel Federman1 shared
- Julie A Womack1 shared
Most similar at Philadelphia Va Medical Center
Same institution · by research overlap
- Henry Richard Kranzler$26,719,773
Others in their field
Top investigators on “Aging”
- Lawrence Corey · Fred Hutchinson Cancer Center$506,603,345
- David R. Weir · University Of Michigan At Ann Arbor$421,002,438
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$351,438,389
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$281,021,854
- George R Seage · Abt Associates, Inc.$218,167,298
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$210,610,900
Research focus
AgingAlcohol ConsumptionAlcoholsVeteransCohort StudiesHiv InfectionsCohortCollaborationsPharmaceutical PreparationsHepatitis CMedicalCaringResearch PersonnelAntiretroviral TherapyAlcohol Or Other Drugs UsePositioning AttributePolypharmacyObservational StudyBasePatient Self-ReportIndexingAnti-Retroviral AgentsLaboratoriesFunding
Grant awards (103)
Aging Well with HIV through Alcohol Research and Risk Reduction and Education (AWAR3E) Center$1,493,442
P60 · FY2025 · AA · contact PI
The HIV and Alcohol Research center focused on Polypharmacy (HARP)$1,268,582
P01 · FY2025 · AA · contact PI
AWARE Administrative and Data Analytics Core$461,501
P60 · FY2025 · AA · contact PI
Personalizing Risk from Alcohol among HIV+/-: Genetics, Medication Toxicity and PEth$300,561
P01 · FY2025 · AA · contact PI
Administration and Data Analytic Core$299,818
P01 · FY2025 · AA · contact PI
Genetic Vulnerability for Sustained Multi-Substance Use in MVP$0
I01 · FY2025 · VA
The HIV and Alcohol Research center focused on Polypharmacy (HARP)$1,288,629
P01 · FY2024 · AA · contact PI
Administration and Data Analytic Core$303,425
P01 · FY2024 · AA · contact PI
Personalizing Risk from Alcohol among HIV+/-: Genetics, Medication Toxicity and PEth$301,442
P01 · FY2024 · AA · contact PI
Genetic Vulnerability for Sustained Multi-Substance Use in MVP$0
I01 · FY2024 · VA · contact PI
Genetic Vulnerability for Sustained Multi-Substance Use in MVP$0
I01 · FY2024 · VA
The HIV and Alcohol Research center focused on Polypharmacy (HARP)$1,180,102
P01 · FY2023 · AA · contact PI
Personalizing Risk from Alcohol among HIV+/-: Genetics, Medication Toxicity and PEth$281,651
P01 · FY2023 · AA · contact PI
Administration and Data Analytic Core$279,499
P01 · FY2023 · AA · contact PI
The HIV and Alcohol Research center focused on Polypharmacy (HARP)$130,228
P01 · FY2023 · AA · contact PI
Genetic Vulnerability for Sustained Multi-Substance Use in MVP$0
I01 · FY2023 · VA · contact PI
The HIV and Alcohol Research center focused on Polypharmacy (HARP)$1,203,656
P01 · FY2022 · AA · contact PI
Administration and Data Analytic Core$296,212
P01 · FY2022 · AA · contact PI
Personalizing Risk from Alcohol among HIV+/-: Genetics, Medication Toxicity and PEth$284,136
P01 · FY2022 · AA · contact PI
Genetic Vulnerability for Sustained Multi-Substance Use in MVP$0
I01 · FY2022 · VA · contact PI
The HIV and Alcohol Research center focused on Polypharmacy (HARP)$1,252,041
P01 · FY2021 · AA · contact PI
3/3 COMpAAAS Tripartite: ART-CC, KP, and VA$519,196
U01 · FY2021 · AA · contact PI
Administration and Data Analytic Core$322,314
P01 · FY2021 · AA · contact PI
Personalizing Risk from Alcohol among HIV+/-: Genetics, Medication Toxicity and PEth$295,761
P01 · FY2021 · AA · contact PI
Genetic Vulnerability for Sustained Multi-Substance Use in MVP$0
I01 · FY2021 · VA · contact PI
2/6 COMpAAAS U01: Observation Study$891,895
U01 · FY2020 · AA · contact PI
3/3 COMpAAAS Tripartite: ART-CC, KP, and VA$580,192
U01 · FY2020 · AA · contact PI
(PQ4)HIV and Aging Mechanisms for Hepatocellular Cancer$470,334
R01 · FY2020 · CA · contact PI
1/6 COMpAAAS U24: Coordinating Center$234,253
U24 · FY2020 · AA · contact PI
Administrative Supplement - Financial Incentives, Randomization with Stepped Treatment (FIRST) Trial$100,000
U01 · FY2020 · AA · contact PI
Genetic Vulnerability for Sustained Multi-Substance Use in MVP$0
I01 · FY2020 · VA · contact PI
2/6 COMpAAAS U01: Observation Study$1,000,702
U01 · FY2019 · AA · contact PI
3/3 COMpAAAS Tripartite: ART-CC, KP, and VA$585,586
U01 · FY2019 · AA · contact PI
(PQ4)HIV and Aging Mechanisms for Hepatocellular Cancer$454,026
R01 · FY2019 · CA · contact PI
1/6 COMpAAAS U24: Coordinating Center$234,253
U24 · FY2019 · AA · contact PI
2/6 COMpAAAS U01: Observation Study$1,004,763
U01 · FY2018 · AA · contact PI
3/3 COMpAAAS Tripartite: ART-CC, KP, and VA$591,994
U01 · FY2018 · AA · contact PI
(PQ4)HIV and Aging Mechanisms for Hepatocellular Cancer$512,833
R01 · FY2018 · CA · contact PI
1/6 COMpAAAS U24: Coordinating Center$234,253
U24 · FY2018 · AA · contact PI
2/6 COMpAAAS U01: Observation Study$1,006,227
U01 · FY2017 · AA · contact PI
3/3 COMpAAAS Tripartite: ART-CC, KP, and VA$587,980
U01 · FY2017 · AA · contact PI
(PQ4)HIV and Aging Mechanisms for Hepatocellular Cancer$527,068
R01 · FY2017 · CA · contact PI
1/6 COMpAAAS U24: Coordinating Center$235,620
U24 · FY2017 · AA · contact PI
Clinical and Health Services Research Core$227,769
P30 · FY2017 · MH · contact PI
21st International Workshop on HIV and Hepatitis Observational Databases (IWHOD)$58,000
R13 · FY2017 · AI · contact PI
Genetic Vulnerability for Sustained Multi-Substance Use in MVP$0
I01 · FY2017 · VA
2/6 COMpAAAS U01: Observation Study$1,066,579
U01 · FY2016 · AA · contact PI
(PQ4)HIV and Aging Mechanisms for Hepatocellular Cancer$563,374
R01 · FY2016 · CA · contact PI
1/6 COMpAAAS U24: Coordinating Center$235,620
U24 · FY2016 · AA · contact PI
Clinical and Health Services Research Core$226,904
P30 · FY2016 · MH · contact PI
CHAART Consortia Scientific Meetings$73,499
U13 · FY2016 · AA · contact PI
20th International Workshop on HIV Observational Databases (IWHOD)$53,143
R13 · FY2016 · AI · contact PI
Consortium to improve OutcoMes in HIV/Aids, Alcohol, Aging & multi-Substance use$742,893
U24 · FY2015 · AA · contact PI
Alcohol and Multisubstance Use in the Veterans Aging Cohort Study$476,948
U01 · FY2015 · AA · contact PI
Translational Research on Alcohol, Immunodeficiency, and Aging In COMpAAAS$455,028
U24 · FY2015 · AA · contact PI
Using the VACS Index to track health outcomes associated with changes in drug use$390,775
R01 · FY2015 · DA
Clinical and Health Services Research Core$226,904
P30 · FY2015 · MH · contact PI
Consortium to improve OutcoMes in HIV/Aids, Alcohol, Aging & multi-Substance use$75,000
U24 · FY2015 · AA · contact PI
CHAART Consortia Scientific Meetings$73,499
U13 · FY2015 · AA · contact PI
Consortium to improve OutcoMes in HIV/Aids, Alcohol, Aging & multi-Substance use$752,306
U24 · FY2014 · AA · contact PI
Alcohol and Multisubstance Use in the Veterans Aging Cohort Study$493,340
U01 · FY2014 · AA · contact PI
Translational Research on Alcohol, Immunodeficiency, and Aging In COMpAAAS$425,927
U24 · FY2014 · AA · contact PI
Using the VACS Index to track health outcomes associated with changes in drug use$396,726
R01 · FY2014 · DA
Clinical and Health Services Research Core$226,904
P30 · FY2014 · MH · contact PI
CHAART Consortia Scientific Meetings$74,821
U13 · FY2014 · AA · contact PI
Consortium to improve OutcoMes in HIV/Aids, Alcohol, Aging & multi-Substance use$893,934
U24 · FY2013 · AA · contact PI
Alcohol and Multisubstance Use in the Veterans Aging Cohort Study$506,079
U01 · FY2013 · AA · contact PI
Translational Research on Alcohol, Immunodeficiency, and Aging In COMpAAAS$416,690
U24 · FY2013 · AA · contact PI
Using the VACS Index to track health outcomes associated with changes in drug use$401,170
R01 · FY2013 · DA
Clinical and Health Services Research Core$162,074
P30 · FY2013 · MH · contact PI
Sex Disparities in Overall Response to ART Among HIV Infected Individuals$100,000
U24 · FY2013 · AA · contact PI
Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans$1,057,149
R01 · FY2012 · HL
Consortium to improve OutcoMes in HIV/Aids, Alcohol, Aging & multi-Substance use$757,364
U24 · FY2012 · AA · contact PI
Alcohol and Multisubstance Use in the Veterans Aging Cohort Study$581,155
U01 · FY2012 · AA · contact PI
Translational Research on Alcohol, Immunodeficiency, and Aging In COMpAAAS$509,581
U24 · FY2012 · AA · contact PI
Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans$420,959
R01 · FY2012 · HL
Consortium to improve OutcoMes in HIV/Aids, Alcohol, Aging & multi-Substance use$198,944
U24 · FY2012 · AA · contact PI
Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans$986,138
R01 · FY2011 · HL
Consortium to improve OutcoMes in HIV/Aids, Alcohol, Aging & multi-Substance use$777,196
U24 · FY2011 · AA · contact PI
Alcohol and Multisubstance Use in the Veterans Aging Cohort Study$596,217
U01 · FY2011 · AA · contact PI
Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans$274,726
R01 · FY2011 · HL
Alcohol Associated Outcomes Among HIV+/- Aging Veterans$2,519,900
U10 · FY2010 · AA · contact PI
Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans$878,370
R01 · FY2010 · HL
Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans$97,568
R01 · FY2010 · HL
Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans$51,686
R01 · FY2010 · HL
Alcohol Associated Outcomes Among HIV+/- Aging Veterans$2,428,227
U10 · FY2009 · AA · contact PI
Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans$835,848
R01 · FY2009 · HL
Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans$50,586
R01 · FY2009 · HL
Alcohol Associated Outcomes Among HIV+/- Aging Veterans$2,516,995
U10 · FY2008 · AA · contact PI
Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans$978,869
R01 · FY2008 · HL
Alcohol Associated Outcomes Among HIV+/- Aging Veterans$2,503,031
U10 · FY2007 · AA · contact PI
Alcohol Associated Outcomes Among HIV+/- Aging Veterans$2,701,057
U10 · FY2006 · AA · contact PI
Alcohol Associated Outcomes Among HIV+/-Aging Veterans$2,631,852
U01 · FY2005 · AA
Alcohol Associated Outcomes Among HIV+/-Aging Veterans$2,685,761
U01 · FY2004 · AA
Alcohol Associated Outcomes Among HIV+/-Aging Veterans$2,551,637
U01 · FY2003 · AA
Alcohol Associated Outcomes Among HIV+/-Aging Veterans$1,516,807
U01 · FY2002 · AA
Alcohol Associated Outcomes Among HIV+/-Aging Veterans$622,568
U01 · FY2002 · AA
MEDIATORS OF AGE ASSOCIATED OUTCOMES IN HIV INFECTION$152,162
K23 · FY2002 · AG
Alcohol Associated Outcomes Among HIV+/-Aging Veterans$140,705
U01 · FY2002 · AA
Alcohol Associated Outcomes Among HIV+/-Aging Veterans$74,999
R01 · FY2002 · AA
Alcohol Associated Outcomes Among HIV+/-Aging Veterans$1,496,218
R01 · FY2001 · AA
MEDIATORS OF AGE ASSOCIATED OUTCOMES IN HIV INFECTION$152,169
K23 · FY2001 · AG
MEDIATORS OF AGE ASSOCIATED OUTCOMES IN HIV INFECTION$152,080
K23 · FY2000 · AG